8-K: Centene Reports Strong Q1 2025 Results, Raises Full-Year Revenue Guidance

Centene Corporation announces a 28% increase in adjusted diluted EPS for Q1 2025 and raises its full-year premium and service revenues guidance by $6 billion.

Summary

• Centene Corporation reported its financial results for the first quarter ended March 31, 2025.
• Total revenues reached $46.62 billion, with premium and service revenues at $42.489 billion.
• GAAP diluted EPS was $2.63, while adjusted diluted EPS was $2.90, a 28% increase from Q1 2024.
• The company experienced a 17% year-over-year growth in premium and service revenue.
• Membership increased by 29% in the Marketplace and 22% in Medicare PDP compared to the first quarter of 2024.
• Centene increased its 2025 premium and service revenues guidance by $6.0 billion, driven by strong Marketplace enrollment and Medicare member retention.
• The company reiterated its full-year 2025 adjusted diluted earnings per share outlook of greater than $7.25.
• Cash flow provided by operations for the first quarter of 2025 was $1.5 billion.
• The company is increasing its 2025 premium and service revenues guidance range to $164.0 billion to $166.0 billion.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong financial results, increased guidance, and membership growth. While there are some challenges noted, the overall tone is optimistic and indicates a healthy business trajectory.

Positives

• Adjusted diluted EPS increased by 28% year-over-year.
• Premium and service revenues saw a significant increase of 17%.
• Membership growth was strong in both the Marketplace (29%) and Medicare PDP (22%) segments.
• The company raised its full-year revenue guidance by $6.0 billion.
• Centene reiterated its adjusted diluted EPS guidance of greater than $7.25 for 2025.
• SilverSummit Healthplan, Inc., was selected by the Nevada Department of Health and Human Services to continue to provide services for its Medicaid managed care program.
• Meridian Health Plan of Illinois, Inc., was selected by the Illinois Department of Healthcare and Family Services to continue providing Medicare and Medicaid services for dually eligible Illinoisans.

Negatives

• The health benefits ratio (HBR) increased to 87.5% from 87.1% in the comparable period in 2024, primarily driven by a higher Medicaid HBR due to influenza-and-like illnesses.
• The effective tax rate increased to 24.7% for the first quarter of 2025, compared to 21.4% in the first quarter of 2024.
• Days in claims payable (DCP) decreased by four days as compared to the first and fourth quarters of 2024 driven by a significant increase in PDP revenue as a result of the IRA.

Risks

• The company faces risks related to changes in laws and regulations, including the renewal and modification of enhanced advance premium tax credits associated with the Marketplace product.
• Centene's ability to maintain or improve CMS Star ratings and other quality scores could impact revenue and future growth.
• Fluctuations in medical utilization rates and the ability to accurately predict and manage health benefits expenses pose ongoing risks.
• Competition for providers, broker distribution networks, and contract reprocurements could affect the company's performance.
• Cyber-attacks or other data security incidents could disrupt operations and lead to compliance issues.
• The company faces uncertainty concerning government shutdowns, debt ceilings or funding.

Future Outlook

Centene is increasing its 2025 premium and service revenues guidance range by $6.0 billion to a range of $164.0 billion to $166.0 billion and reiterates its 2025 adjusted diluted EPS guidance floor of greater than $7.25.

Management Comments

• Our first quarter results demonstrate the resiliency of Centene's platform and the progress we are making as an organization while navigating a dynamic policy landscape, said Chief Executive Officer of Centene, Sarah M. London.
• We are pleased to reiterate our full year 2025 adjusted diluted earnings per share outlook of greater than $7.25 and continue to see attractive opportunities to grow from the strength of our core businesses in the years to come.

Industry Context

Centene's focus on government-sponsored healthcare programs aligns with the increasing demand for managed care services in Medicaid and Medicare. The company's growth in the Marketplace reflects the ongoing expansion of the Affordable Care Act and the increasing number of individuals seeking affordable health insurance options.

Comparison to Industry Standards

• Centene's adjusted diluted EPS growth of 28% in Q1 2025 is a strong performance compared to its peers in the managed care industry.
• UnitedHealth Group, another major player, reported a 13% increase in adjusted EPS for its most recent quarter.
• Humana's recent results showed a more modest growth rate, highlighting Centene's relative outperformance.
• Centene's HBR of 87.5% is within the typical range for managed care organizations, but the increase warrants monitoring.
• Competitors like Molina Healthcare have been focusing on improving their HBR through cost management initiatives.

Stakeholder Impact

• Shareholders will likely react positively to the strong financial results and increased guidance.
• Employees may benefit from the company's growth and success.
• Customers will continue to receive healthcare services through Centene's various programs.
• Suppliers and providers will continue to partner with Centene to deliver healthcare services.
• The company's financial stability benefits creditors.

Next Steps

• The company will host a conference call on April 25, 2025, to discuss the financial results.
• Centene will continue to focus on growing its core businesses and navigating the dynamic policy landscape.
• The company will work to implement the new contracts in Nevada and Illinois starting in January 2026.

Key Dates

Keywords

Centene, financial results, Q1 2025, EPS, revenue, Medicaid, Medicare, Marketplace, guidance, membership, health benefits ratio